Checkmate 214 Data Favorable RCC Patients Better on Targeted Therapies - 102191

Spotlight
Video

Checkmate 214 Data Favorable RCC Patients Better on Targeted Therapies

Cancer-News has 28 videos Subscribe Here

Loading........
Description: Scott S. Tykodi, MD of Seattle Cancer Care Alliance discusses the recently released Checkmate 214 data and how favorable RCC patients may be better served staying on targeted therapies rather than immunotherapy treatments.
Shared By : Cancer-News
Posted on : 09/18/17
Added : 4 months ago
Category : Kidney Cancer



Recommended

Nothing found.

More From Cancer-News

Nothing found.